Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study

Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study

Abstract Background This observational study investigated the safety and effectiveness of continuous erythropoietin receptor activator in patients with renal anemia in Japan. Methods Patients were enrolled between August 2011 and November 2015 and followed for up to 1 year. Outcomes were analyzed ac...

Full description

Bibliographic Details
Main Authors: Hidehiro Tabata, Hiroyuki Kanno, Ayako Murayama, Tadashi Ishii, Ryosuke Harada, Yukio Udagawa
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Renal Replacement Therapy
Subjects:
Chronic kidney disease
Continuous erythropoietin receptor activator
Dialysis
Methoxy polyethylene glycol-epoetin beta
Anemia
Online Access:http://link.springer.com/article/10.1186/s41100-019-0221-z

Internet

http://link.springer.com/article/10.1186/s41100-019-0221-z

Similar Items